Prelude Therapeutics Incorporated
NASDAQ:PRLD · NASDAQ Global Select
-$0.14 today
Vol 0.86M · Avg 0.38M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+414.29%
Period High
$5.52
Period Low
$0.78
Latest
$4.32
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.21M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$242.49M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$234.14M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$213.94M
Inventiva S.A.
NASDAQ:IVA
$184.02M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$169.65M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.20M
Immuneering Corporation
NASDAQ:IMRX
$157.19M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$128.29M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$117.44M
What is the latest PRLD filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does PRLD have?
Intrinsic Alpha currently shows 20 recent filings for PRLD.
Explore More
Continue the stock analysis
Jump to another research area for this company.